Clinical trials session
ALERT: Asthma in adults and children
14:30
Introduction
1
4611
14:35
Late Breaking Abstract - Masitinib in severe asthma: Results from a randomized, phase 3 trial
P. Chanez(Marseille, France)
COI
2
14:38
Late Breaking Abstract - Dupilumab long-term safety and efficacy in patients with asthma: LIBERTY ASTHMA TRAVERSE
M. Wechsler(Denver, United States)
COI
3
14:41
Late Breaking Abstract - LUSTER-1 and -2: randomised controlled trials of fevipiprant in severe asthma
C. Brightling(Leicester (Leicestershire), United Kingdom)
COI
4
14:44
Wrap-up by discussant and discussion
C. Porsbjerg(Copenhagen, Denmark)
COI
5
4615
14:59
Late Breaking Abstract - Add-on mepolizumab for chronic rhinosinusitis with nasal polyps: SYNAPSE study
C. Hopkins(London, United Kingdom)
COI
6
15:02
Effect of controller prescribing according to rs1042713 genotype on asthma related quality of life in young people (PACT): a randomized controlled trial
T. Ruffles(hove, United Kingdom)
COI
7
15:05
Late Breaking Abstract - Corticosteroid optimisation in severe asthma using composite biomarkers to adjust dose versus a symptom/risk-based algorithm
L. Heaney(Belfast (Belfast), United Kingdom)
COI
8
15:08
Wrap-up by discussant and discussion
M. Gaga(Athens, Greece)
COI
9
4619
. . .
